This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms

This study has been completed.
Information provided by (Responsible Party):
W.L.Gore & Associates Identifier:
First received: December 20, 2007
Last updated: August 6, 2014
Last verified: August 2014
The purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending thoracic aortic (DTA) aneurysms

Condition Intervention
Aortic Aneurysm, Thoracic Device: GORE TAG® Thoracic Endoprosthesis

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Clinical Evaluation of the GORE TAG Thoracic Endoprosthesis in the Primary Treatment of Descending Thoracic Aortic Aneurysms

Resource links provided by NLM:

Further study details as provided by W.L.Gore & Associates:

Primary Outcome Measures:
  • Aneurysm Related Death [ Time Frame: 5 years ]
    Freedom from aneurysm related mortality for TAG 05-02 subjects

Secondary Outcome Measures:
  • A Subset of Major Adverse Events Will be Evaluated in Subjects Treated With the TAG Device and Subjects Treated With Open Surgical Repair. [ Time Frame: 5 years ]
    Proportion of subjects in TAG 05-02 with MAEs

Enrollment: 150
Study Start Date: August 2005
Study Completion Date: April 2013
Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
GORE TAG® Thoracic Endoprosthesis Device: GORE TAG® Thoracic Endoprosthesis


Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Descending thoracic aortic aneurysm deemed to warrant surgical repair:

    1. Fusiform aneurysm greater than or equal to 2 times diameter of normal adjacent aorta
    2. Saccular aneurysm
  2. Anatomy meets GORE TAG Thoracic Endoprosthesis specification criteria as indicated in the Instructions for Use (Appendix A)
  3. Minimum 2 cm non-aneurysmal segment proximal and distal to the aneurysm

    • <60 degree angle in the aortic arch may require additional length of non-aneurysmal segment if the arch is included in the treatment segment

  4. Life expectancy > 2 years
  5. Surgical Candidate

    • ASA Class I, II, III, or IV
    • NYHA Class I, II, III or no heart disease
  6. Male or infertile female
  7. Minimum 21 years of age
  8. Able to comply with protocol requirements
  9. Signed Informed Consent Form

Exclusion Criteria:

  1. 4 mm aortic taper and inability to use devices of different diameters, to compensate for the taper, in the treatment area of the aorta
  2. Significant thrombus at the proximal or distal implantation zones
  3. Mycotic aneurysm
  4. Hemodynamically unstable aneurysm rupture (non-contained aneurysm rupture)
  5. Acute or chronic aortic dissection
  6. Planned occlusion of the left carotid or celiac arteries
  7. "Planned" concomitant surgical procedure (other than left subclavian transposition) or previous major surgery within 30 days
  8. Myocardial infarction or cerebral vascular accident within 6 weeks
  9. Severe respiratory insufficiency sufficient that precludes open thoracotomy
  10. Renal insufficiency (Creatinine > 2.0 mg/dL) with or without dialysis
  11. Degenerative connective tissue disease, e.g., Marfan or Ehler-Danlos Syndrome
  12. Participation in another investigational device or drug study within 1 year
  13. Documented history of drug abuse within 6 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00590759

  Show 25 Study Locations
Sponsors and Collaborators
W.L.Gore & Associates
Principal Investigator: Mark Morasch, M.D. St. Vincent's Healthcare, Billings MT
  More Information

Responsible Party: W.L.Gore & Associates Identifier: NCT00590759     History of Changes
Other Study ID Numbers: TAG 05-02
Study First Received: December 20, 2007
Results First Received: June 10, 2014
Last Updated: August 6, 2014

Additional relevant MeSH terms:
Aortic Aneurysm
Aortic Aneurysm, Thoracic
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases processed this record on September 25, 2017